methotrexate has been researched along with Duodenal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, M; Inokuma, T; Shimeno, N; Toyonaga, H | 1 |
| Grindey, GB; Pavelic, ZP; Semon, JH | 1 |
2 other study(ies) available for methotrexate and Duodenal Diseases
| Article | Year |
|---|---|
Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Doxorubicin; Duodenal Diseases; Endoscopy, Digestive System; Female; Humans; Lymphoproliferative Disorders; Methotrexate; Prednisone; Recurrence; Rituximab; Stomach Diseases; Vincristine; Withholding Treatment | 2019 |
Modulation versus rescue of antimetabolite toxicity by salvage metabolites administered by continuous infusion.
Topics: Animals; Drug Therapy, Combination; Duodenal Diseases; Female; Infusions, Parenteral; Inosine; Lethal Dose 50; Leucovorin; Leukemia L1210; Methotrexate; Mice; Mice, Inbred DBA; Thymidine | 1978 |